angiotensin ii has been researched along with lisinopril in 144 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (6.25) | 18.7374 |
| 1990's | 73 (50.69) | 18.2507 |
| 2000's | 42 (29.17) | 29.6817 |
| 2010's | 15 (10.42) | 24.3611 |
| 2020's | 5 (3.47) | 2.80 |
| Authors | Studies |
|---|---|
| Hiramori, K; Imanashi, M; Ito, K; Kawamura, M; Matsushima, Y | 1 |
| Bost, JG; Leenders, PJ; Nelissen-Vrancken, MH; Smits, JF; Struijker-Boudier, HA | 1 |
| Babalis, D; Benetos, A; Levy, BI; Stefas, L | 1 |
| Bahner, U; Geiger, H; Heidland, A; Hofmann, M; Kraus, I; Luft, FC; Palkovits, M | 1 |
| Cleland, JG; Frost, G; Krikler, S; Oakley, CM; Shah, D | 1 |
| Bell, L; Luthringer, DJ; Madri, JA; Warren, SL | 1 |
| De Mey, JG; Schiffers, PM; Struyker-Boudier, HA | 1 |
| Chai, SY; Jackson, B; Johnston, CI; Kohzuki, M; Mendelsohn, FA; Paxton, D; Perich, R | 1 |
| de Jong, PE; de Zeeuw, D; Heeg, JE; van der Hem, GK | 1 |
| Bennett, T; Gardiner, SM; Tomlinson, KC | 1 |
| Franco-Saenz, R; Lotshaw, DP; Mulrow, PJ; Oda, H | 1 |
| Akabane, S; Imanishi, M; Ito, K; Kawamura, M; Kuramochi, M; Matsushima, Y; Omae, T | 1 |
| Ganten, D; Hellmann, T; Keuneke, C; Metzger, R; Peters, J; Yacullo, R | 1 |
| Randall, RD; Zimmerman, BG | 1 |
| Dickstein, K | 1 |
| Franco-Saenz, R; Kusano, E; Mulrow, PJ; Shier, DN; Stoner, GD | 1 |
| Brunner, HR; Nussberger, J; Waeber, B | 1 |
| Ann, HS; Jackson, RM; Narkates, AJ; Oparil, S | 1 |
| Hidaka, H; Oka, H; Sato, R; Sawada, S | 1 |
| Karlberg, BE; Rosenqvist, U | 1 |
| Fyhrquist, F; Grönhagen-Riska, C; Karlberg, BE; Ohman, KP; Tikkanen, I | 1 |
| Aarsland, T; Abrahamsen, AM; Dickstein, K; Kremer, D; Woie, L | 1 |
| Brunner, DB; Brunner, HR; Nussberger, J; Waeber, B | 1 |
| Kawamura, K; Kubota, J; Mori, T; Nishimura, H; Ueyama, M | 1 |
| Dean, RH; Ferrario, CM; Fuller, SB; Nakamoto, H; Robaczewski, DL; Winicov, E | 1 |
| Auch-Schwelk, W; Duske, E; Fleck, E; Hess, B; Hildebrandt, AG; Klein, U; Regitz-Zagrosek, V; Steffen, C | 1 |
| Ratajska, A; Sun, Y; Weber, KT | 1 |
| Caputo, L; Lévy, BI; Tedgui, A | 1 |
| Cargill, RI; Kiely, DG; Lipworth, BJ | 1 |
| Aubert, JF; Brunner, HR; Niederberger, M; Nussberger, J; Waeber, B | 1 |
| el Amrani, AI; Gonzales, MF; Menard, J; Michel, JB | 1 |
| Bachmann, J; Bachmann, S; Bader, M; Böhm, M; Ganten, D; Kim, S; Lee, MA | 1 |
| McInnes, GT; Millar, EA; Thomson, NC | 1 |
| Devineni, VR; Henegar, JR; Janicki, JS; Kabour, A | 1 |
| Johnson, KA; Trilli, LE | 1 |
| Sun, Y; Weber, KT | 1 |
| Martinez-Maldonado, M; Pimentel, JL; Wang, S | 1 |
| Faison, EP; Lacourcière, Y; Lefebvre, J; Nakhle, G; Nelson, EB; Snavely, DB | 1 |
| Campbell, DJ; Duncan, AM; Kladis, A | 1 |
| Brosnihan, KB; Ferrario, CM; Ganten, D; Kumagai, H; Moriguchi, A | 1 |
| Auch-Schwelk, W; Betz, M; Duske, E; Fleck, E; Hink, U; Unkelbach, M | 1 |
| Ratajska, A; Sun, Y; Weber, KT; Zhou, G | 1 |
| Camargo, LA; Luiz, AC; Menani, JV; Renzi, A; Saad, WA; Silveira, JE | 1 |
| Averill, DB; Ferrario, CM; Khosla, MC; Kumagai, H | 1 |
| Bumpus, FM; Husain, A; Kinoshita, A; Urata, H | 1 |
| Brilla, CG; Campbell, SE; Guarda, E; Sriram, K; Weber, KT; Zhou, G | 1 |
| Arcaro, G; Bolner, A; Covi, G; Gelmini, G; Lechi, A; Piemonte, G; Sheiban, I; Tonni, S | 1 |
| Campbell, SE; Cicila, GT; Katwa, LC; Lee, SJ; Tyagi, SC; Weber, KT | 2 |
| Bertani, T; Colosio, V; Corna, D; Donadelli, R; Facchinetti, D; Luzzana, E; Maffi, R; Remuzzi, G; Testa, D; Zoja, C | 1 |
| Devaux, B; Henry, JP; Macé, B; Mulder, P; Richard, V; Thibout, E; Thuillez, C; Wimart, MC | 1 |
| Hama, J; Horiuchi, M; Kai, T; Kamoi, K; Kino, H; Nagata, S; Shimada, S; Sugimura, K; Takenaka, T; Yamamoto, Y | 1 |
| Ganjam, VK; Ramires, FJ; Sun, Y; Weber, KT; Zhou, G | 1 |
| Black, HR; Graff, A; Levine, J; Mallows, S; Ruff, D; Shi, Y; Shute, D; Stoltz, R | 1 |
| Buñag, RD; Kerecsen, L; Mellick, JR; Montemayor, E | 1 |
| Albrecht, D; Ganten, D; Henklein, P | 1 |
| Amici, D; Bramucci, M; Gobbetti, A; Maccari, E; Miano, A; Murri, O; Quassinti, L; Zerani, M | 1 |
| Chappell, MC; Ferrario, CM; Iyer, SN | 1 |
| Chappell, MC; Ferrario, CM; Pirro, NT; Sykes, A | 1 |
| Averill, DB; Chappell, MC; Diz, DI; Ferrario, CM; Iyer, SN | 1 |
| Abbate, M; Benigni, A; Bruzzi, I; Capitanio, M; Corna, D; Donadelli, R; Oldroyd, S; Remuzzi, G; Zoja, C | 1 |
| Stoschitzky, K | 1 |
| Williams, B | 1 |
| Campbell, SE; Dhalla, AK; Kandala, JC; Katwa, LC; Sun, Y; Tyagi, SC; Weber, KT | 1 |
| Chappell, MC; Ferrario, CM; Ganten, D; Iyer, SN; Yamada, K | 1 |
| Brechler, V; Deschepper, CF; Gallo-Payet, N; Laflamme, L; Reudelhuber, TL | 1 |
| Hilgers, KF; Mann, JF; Schmieder, RE; Scrogin, KE; Veelken, R | 1 |
| Fukamizu, A; Ishikawa, K; Kai, T; Kurooka, A; Murakami, K; Shimada, S; Sugimura, K; Takenaka, T | 1 |
| Bernier, NJ; Kaiya, H; Perry, SF; Takei, Y | 1 |
| Ishikawa, K; Kai, T; Kurooka, A; Shimada, S; Sugimura, K | 1 |
| Amici, D; Bramucci, M; Maccari, E; Miano, A; Murri, O; Quassinti, L | 1 |
| Allen, B; Buñag, R; Mellick, J | 1 |
| Brosnihan, KB; Chappell, MC; Ferrario, CM; Fukuhara, M; Iyer, SN; Yamada, K | 1 |
| Ang, E; Baraboutis, J; Chaudhary, G; Deshmukh, S; Filippatos, G; Gidea, C; Ibarra-Sunga, O; Uhal, BD; Wang, R; Zagariya, A | 1 |
| Conigliaro, RL; Gleason, PP | 1 |
| Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
| Jin, D; Miyazaki, M; Sakaguchi, M; Takai, S | 1 |
| Bellissant, E; Durand-Castel, X; Goineau, S; Guillo, P; Pape, D | 1 |
| Bernier, NJ; Gilmour, KM; Perry, SF; Takei, Y | 1 |
| Ezan, E; Fraser, C; Junot, C; MacFadyen, R; Morton, JJ; Robson, J; Struthers, AD | 1 |
| Ang, E; Ibarra-Sunga, O; Uhal, BD; Wang, R; Zagariya, A | 1 |
| Damme, U; Daniel, WG; Garlichs, CD; Mügge, A; Plötze, K; Schmeisser, A; Zhang, H | 1 |
| Cukon, S; Ennezat, PV; Hammer, A; Infeld, J; Jorde, UP; Le Jemtel, TH; Lisker, J; Sonnenblick, EH; Suryadevara, V | 1 |
| DE Jong, PE; DE Zeeuw, D; Navis, G; Wapstra, FH | 1 |
| Cassat, C; Desachy, A; François, B; Gastinne, H; Normand, S; Vignon, P | 1 |
| Block, AJ; Isaac, D; Kerut, EK; Pfeffer, MA; Porter, CB; Proulx, G; Qian, C; Rouleau, JL; Sestier, F; Stewart, DJ | 1 |
| Alam, G; Choudhary, G; Gidea, C; Lalude, O; Oezatalay, D; Pinillos, H; Uhal, BD; Wang, R; Zagariya, A | 1 |
| Akao, M; Horie, M; Kouchi, I; Murakami, T; Otani, H; Sakurai, T; Sasayama, S; Takano, M | 1 |
| Jin, D; Miyazaki, M; Sakaguchi, M; Takai, S; Yamada, M | 1 |
| Amaral, SL; Greene, AS; Linderman, JR; Morse, MM | 1 |
| Benigni, A; Gagliardini, E; Grunkemeyer, JA; Kalluri, R; Remuzzi, G; Tomasoni, S; Zoja, C | 1 |
| Joles, JA; Klok, PA; Kuipers, F; Navis, G; Smit-van Oosten, A; Stegeman, CA; Tiebosch, AT; van Goor, H | 1 |
| Fagard, RH; Lijnen, PJ; Petrov, VV | 2 |
| Lapner, KN; Perry, SF | 1 |
| Farquharson, CA; Struthers, AD | 1 |
| Benigni, A; Donadoni, C; Fassi, A; Gagliardini, E; Lepre, MS; Remuzzi, A; Remuzzi, G; Sangalli, F | 1 |
| Akinboboye, OO; Bergmann, SR; Chou, RL | 1 |
| Anguita Sánchez, M | 1 |
| Goto, O; Imoto, T; Ishida, A; Miyoshi, M; Nagata, K; Watanabe, T | 1 |
| Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH | 1 |
| Frank, R; Gauthier, BG; Ramek, J; Stoll, ML; Trachtman, H; Vergara, M | 1 |
| Alexiou, T; Bernstein, KE; Campbell, DJ; Corvol, P; Fuchs, S; McKinley, MJ; Xiao, HD | 1 |
| Ando, T; Itoh, M; Joh, T; Kuno, A; Masuda, K; Nakamura, S; Nomura, T; Ogawa, K; Ohara, H; Okamoto, T; Shirai, T; Tang, M; Yamada, T | 1 |
| Fujita, M; Fukamizu, A; Hayashi, I; Itoman, M; Majima, M; Yamashina, S | 1 |
| Sarlos, S; Wilkinson-Berka, JL | 1 |
| Bulbuller, N; Cetiner, M; Gogebakan, O; Ilhan, N; Ilhan, YS; Kirkil, C | 1 |
| Averill, DB; Brosnihan, KB; Chappell, MC; Diz, DI; Ferrario, CM; Gallagher, PE; Jessup, J; Tallant, EA | 1 |
| Bechara, RI; Brown, LA; Guidot, DM; Hart, CM; Joshi, PC; Palacio, A; Pelaez, A; Raynor, R | 1 |
| Ann Tallant, E; Averill, DB; Brosnihan, KB; Chappell, MC; Ferrario, CM; Gallagher, PE; Jessup, J; Smith, RD | 1 |
| Brown, LA; Campbell, DJ; Clempus, RE; Elms, SC; Guidot, DM; Hart, CM; Polikandriotis, JA; Rupnow, HL; Sutliff, RL | 1 |
| Brunner, HR; Burnier, M; Forclaz, A; Hasler, C; Maillard, M; Nussberger, J | 1 |
| Averill, DB; Brosnihan, KB; Chappell, MC; Ferrario, CM; Gallagher, PE; Jessup, JA; Tallant, EA | 1 |
| Dilsizian, V; Eckelman, WC; Jagoda, EM; Loredo, ML; Shirani, J | 1 |
| Dilsizian, V; Eckelman, WC; Narula, J; Narula, N; Shirani, J | 1 |
| Morris, AD; Sharman, DC; Struthers, AD | 1 |
| Boron, WF; Zhou, Y | 1 |
| Corvol, P; Hamming, I; Michaud, AA; Navis, G; Rushworth, CA; Turner, AJ; van Goor, H | 1 |
| Morel, N; Smagghe, G; Szust, J; Van Camp, J; Vercruysse, L | 1 |
| Ahmad, M; Huang, BS; Leenen, FH; Tan, J; White, R | 1 |
| Haider, DG; Jungbauer, A; Kapiotis, S; Mueller, M; Storka, A; Vojtassakova, E; Wolzt, M | 1 |
| Gonzalez-Villalobos, RA; Katsurada, A; Kobori, H; Navar, LG; Satou, R; Semprun-Prieto, LC; Seth, DM | 1 |
| Angus, PW; Brown, L; Burrell, LM; Casley, D; Herath, CB; Jia, Z; Lubel, JS; Tikellis, C; Velkoska, E | 1 |
| Hayashi, T; Inoue, N; Jin, D; Katayama, H; Kitaura, Y; Miyazaki, M; Muramatsu, M; Takai, S; Tamai, H | 1 |
| Gonzalez-Villalobos, RA; Katsurada, A; Kim, C; Kobori, H; Navar, LG; Ohashi, N; Prieto, MC; Satou, R; Semprun-Prieto, LC; Upchurch, GM | 1 |
| Badillo, FH; González-Cortazar, M; Herrera-Ruiz, M; Jiménez-Ferrer, E; Tortoriello, J | 1 |
| Coletta, E; Davies, R; Haddad, H; Leenen, FH; Ruzicka, M; White, R | 1 |
| Abraham, NG; Cheng, J; Falck, JR; Goli, M; Gotlinger, K; Inoue, K; Schwartzman, ML; Sodhi, K; Wu, CC | 1 |
| Alsabeh, R; Bernstein, KE; Billet, S; Chen, X; Datta, V; Fuchs, S; Lin, C; Okwan-Duodu, D; Shen, XZ | 1 |
| Alvarenga, ÉC; Bader, M; Carmona, AK; Casarini, DE; Costa-Neto, CM; Ferreira, AT; Guimarães, PB; Jasiulionis, MG; Martin, RP; Morais, RL; Nakaie, CR; Oliveira, SM; Paredes-Gamero, EJ; Pesquero, JB; Pesquero, JL; Reis, RI; Sabatini, RA; Santos, EL; Shimuta, SI; Siqueira, PD; Teixeira, LG | 1 |
| Harty, DWS; Hunter, N | 1 |
| Chappell, MC; Westwood, BM | 1 |
| Bader, M; Bohlender, J; Ménard, J; Nussberger, J | 1 |
| Burger, D; Chibale, K; Mahajan, A; Reudelhuber, TL; Sturrock, ED; Touyz, RM | 1 |
| Cespedes, C; Cuevas, CA; Inestrosa, NC; Tapia-Rojas, C; Vio, CP | 1 |
| Chu, CS; Hébert, MJ; Hsieh, YJ; Kuo, MC; Shih, SC; Soulez, M; Wu, SJ; Yang, YH | 1 |
| Brzozowski, T; Konturek, SJ; Korbut, R; Kwiecien, S; Madej, J; Olszanecki, R; Pajdo, R; Pawlik, MW; Ptak-Belowska, A; Suski, M; Targosz, A | 1 |
| Alvarenga, EC; Batista, C; Carmona, AK; Carvalho, CC; de Paula, AM; Florentino, RM; Fonseca, MC; Foureaux, G; França, A; Freire, V; Guimarães, PB; Leite, MF; Matias, E; Pesquero, JB | 1 |
| Bhatti, MS; Choudhary, MI; Musharraf, SG; Rahman, AU | 1 |
| Ge, J; Ma, J; Ma, L; Ma, Y; Wu, R; Zou, Y | 1 |
| Fukushima, A; Furihata, T; Kakutani, N; Kinugawa, S; Matsumoto, J; Nambu, H; Takada, S; Yokota, T | 1 |
| Elena Hernandez-Campos, M; Flores-Monroy, J; Lezama-Martinez, D; Martinez-Aguilar, L; Valencia-Hernandez, I | 1 |
| Abouelkheir, M | 1 |
| Abd El-Aal, SA; Al Khabbaz, HJ; Arab, HH; Arafa, EA; Ashour, AM; El-Sheikh, AAK; Kabel, AM; Mahmoud, AM | 1 |
5 review(s) available for angiotensin ii and lisinopril
| Article | Year |
|---|---|
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
Hypoxaemia and the renin-angiotensin system: new answers for old questions.
Topics: Angiotensin II; Animals; Humans; Hypoxia; Lisinopril; Lung Diseases; Oxygen Inhalation Therapy; Pulmonary Circulation; Renin-Angiotensin System | 1994 |
Myocardial fibrosis: role of angiotensin II and aldosterone.
Topics: Aldosterone; Angiotensin II; Animals; Dipeptides; Endomyocardial Fibrosis; Heart; Humans; Lisinopril; Mineralocorticoid Receptor Antagonists; Wound Healing | 1993 |
[Prevention and treatment of congestive heart failure in diabetic patients].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Carbazoles; Cardiotonic Agents; Carvedilol; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Meta-Analysis as Topic; Metoprolol; Prognosis; Propanolamines; Risk Factors; Time Factors | 2002 |
Early imaging in heart failure: exploring novel molecular targets.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Fluorine Radioisotopes; Heart Failure; Humans; Imidazoles; Lisinopril; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Renin-Angiotensin System; Ventricular Remodeling | 2007 |
15 trial(s) available for angiotensin ii and lisinopril
| Article | Year |
|---|---|
Angiotensin-converting enzyme inhibitors, left ventricular dysfunction, and early heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output, Low; Dipeptides; Double-Blind Method; Exercise Test; Glomerular Filtration Rate; Humans; Lisinopril; Male; Middle Aged; Oxygen Consumption; Placebos; Renal Circulation; Stroke Volume; Ventricular Function, Left | 1992 |
Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Female; Humans; Lisinopril; Male; Middle Aged; Proteinuria; Renal Circulation | 1991 |
Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Heart Failure; Hemodynamics; Hormones; Humans; Kinetics; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A; Random Allocation; Renin | 1987 |
Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dipeptides; Enalapril; Humans; Hydralazine; Hypertension, Renovascular; Lisinopril; Middle Aged; Prazosin | 1984 |
Investigation of the mechanism of beta 2-agonist-induced activation of the renin-angiotensin system.
Topics: Administration, Inhalation; Adult; Albuterol; Angiotensin II; Cross-Over Studies; Double-Blind Method; Female; Humans; Lisinopril; Male; Peptidyl-Dipeptidase A; Potassium; Renin; Renin-Angiotensin System | 1995 |
Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Cough; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Lisinopril; Losartan; Male; Prospective Studies; Research Design; Surveys and Questionnaires; Tetrazoles | 1994 |
Left ventricular diastolic function during adrenergic stress in essential hypertension: acute and chronic effects of ACE inhibition.
Topics: Adult; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Catecholamines; Chromatography, High Pressure Liquid; Cold Temperature; Electrocardiography; Female; Humans; Hypertension; Linear Models; Lisinopril; Male; Middle Aged; Renin-Angiotensin System; Stroke Volume; Ventricular Function, Left | 1996 |
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Male; Middle Aged; Safety; Tetrazoles; Treatment Outcome; Valine; Valsartan | 1997 |
Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Chronic Disease; Diuretics; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure; Humans; Lisinopril; Oligopeptides; Peptidyl-Dipeptidase A; Radionuclide Ventriculography; Treatment Outcome; Treatment Refusal | 1999 |
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Double-Blind Method; Endothelin-1; Exercise Tolerance; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Neprilysin; Norepinephrine; Prospective Studies; Pyridines; Radionuclide Ventriculography; Severity of Illness Index; Survival Rate; Thiazepines; Treatment Outcome | 2000 |
Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Vessels; Chronic Disease; Cross-Over Studies; Cross-Sectional Studies; Double-Blind Method; Female; Heart Failure; Humans; Lisinopril; Longitudinal Studies; Male; Middle Aged; Time Factors | 2002 |
Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Coronary Circulation; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Losartan; Male; Middle Aged; Tomography, Emission-Computed | 2002 |
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypertension; Imidazoles; Lisinopril; Male; Olmesartan Medoxomil; Renin; Renin-Angiotensin System; Tetrazoles | 2005 |
Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus.
Topics: Adult; Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Hypertension; Kinetics; Lisinopril; Male; Middle Aged | 2007 |
Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE".
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aorta, Thoracic; Cardiac Catheterization; Coronary Sinus; Female; Humans; Hydrophobic and Hydrophilic Interactions; Hypertension; Lipids; Lisinopril; Male; Middle Aged; Perindopril; Prospective Studies; Pulmonary Wedge Pressure; Quinapril; Renin-Angiotensin System; Tetrahydroisoquinolines; Young Adult | 2010 |
124 other study(ies) available for angiotensin ii and lisinopril
| Article | Year |
|---|---|
Circulating angiotensin II levels under repeated administration of lisinopril in normal subjects.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dipeptides; Humans; Lisinopril; Peptidyl-Dipeptidase A; Renin; Substance Withdrawal Syndrome | 1992 |
Comparison of angiotensin-converting enzyme inhibitors in the rat in perfused hindlimbs and in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Dose-Response Relationship, Drug; Hemodynamics; Hindlimb; Lisinopril; Male; Peptidyl-Dipeptidase A; Perfusion; Rats; Rats, Inbred SHR; Vascular Resistance | 1992 |
Vascular endothelium, mechanical properties of the arterial wall and local angiotensin converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Carotid Arteries; Compliance; Dipeptides; Endothelium, Vascular; In Vitro Techniques; Lisinopril; Male; Potassium Cyanide; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Saralasin | 1992 |
Effects of lisinopril on brain atrial natriuretic factor in uremic rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Dipeptides; Drinking; Hypothalamus; Lisinopril; Male; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Sodium; Urine | 1992 |
Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-src expression.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Cattle; Cell Movement; Cells, Cultured; Enalapril; Endothelium, Vascular; Gene Expression Regulation, Viral; Lisinopril; Plasminogen Activators; Protein Kinases; Proto-Oncogene Proteins pp60(c-src); Receptors, Angiotensin; RNA, Messenger | 1992 |
Effects of angiotensin II and angiotensin converting enzyme inhibitors on contractile and growth responses in isolated carotid arteries of the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carotid Arteries; DNA; Enalapril; In Vitro Techniques; Lisinopril; Male; Rats; Rats, Inbred WKY; Vasoconstriction | 1991 |
Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Autoradiography; Edetic Acid; Enalapril; Enzyme Induction; Kidney; Lisinopril; Lung; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Renin; Testis | 1991 |
Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Enalapril; Heart Rate; Lisinopril; Male; Rats; Rats, Brattleboro; Saralasin; Water Deprivation | 1990 |
Local generation of angiotensin II as a mechanism of aldosterone secretion in rat adrenal capsules.
Topics: Adrenal Glands; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Female; In Vitro Techniques; Lisinopril; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains | 1991 |
A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.
Topics: Administration, Oral; Adult; Angiotensin I; Angiotensin II; Enalapril; Humans; Lisinopril; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Time Factors | 1990 |
The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Captopril; Enalapril; Gene Expression Regulation; Heart; Hydralazine; Hypertension; Isoquinolines; Kidney; Lisinopril; Male; Quinapril; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrahydroisoquinolines | 1990 |
Abolition of long-term vascular influence of renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Vessels; Electric Stimulation; Enalapril; Lisinopril; Male; Nephrectomy; Neural Conduction; Norepinephrine; Peptidyl-Dipeptidase A; Rabbits; Renin; Renin-Angiotensin System; Sodium; Sympathectomy; Sympathetic Nervous System | 1990 |
Production of renin, angiotensin II, and aldosterone by adrenal explant cultures: response to potassium and converting enzyme inhibition.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Survival; Culture Techniques; Enalapril; Female; Lisinopril; Potassium; Rats; Rats, Inbred Strains; Renin; Time Factors | 1989 |
Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats.
Topics: Adaptation, Physiological; Angiotensin I; Angiotensin II; Animals; Dipeptides; Enalapril; Hypoxia; Lisinopril; Lung; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains | 1988 |
An improved method for measuring angiotensin I converting enzyme activity using a highly sensitive angiotensin II radioimmunoassay.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Cross Reactions; Edetic Acid; Enalapril; Leucine; Lisinopril; Oligopeptides; Pepstatins; Peptidyl-Dipeptidase A; Protease Inhibitors; Rabbits; Radioimmunoassay; Renin; Spectrophotometry; Substrate Specificity | 1985 |
Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Female; Humans; Hypertension, Renovascular; Kidney Function Tests; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A | 1986 |
Acute hemodynamic and hormonal effects of MK-521 in congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Dipeptides; Female; Heart Failure; Hemodynamics; Hormones; Humans; Lisinopril; Male; Middle Aged; Renin; Time Factors | 1984 |
Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Anion Exchange Resins; Dipeptides; Enalapril; Ethanol; Humans; Indoles; Kidney; Lisinopril; Male; Radioimmunoassay; Rats; Resins, Synthetic | 1984 |
Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cardiac Output; Cardiomegaly; Heart; Hemodynamics; Hypertension; Kidney; Lisinopril; Male; Organ Size; Rats; Rats, Inbred SHR; Rats, Wistar; Renal Circulation; Tetrazoles | 1995 |
Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension.
Topics: Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Angiotensins; Animals; Arginine; Biphenyl Compounds; Dogs; Hemodynamics; Hypertension, Renovascular; Imidazoles; Lisinopril; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Peptide Fragments; Peptidyl-Dipeptidase A; Tetrazoles | 1995 |
Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists.
Topics: Administration, Oral; Adrenal Cortex; Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cyclosporine; Down-Regulation; Drug Interactions; Imidazoles; Kidney; Lisinopril; Liver; Losartan; Male; Pyridines; Quinolines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Up-Regulation | 1995 |
Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Fibrosis; Immunohistochemistry; Lisinopril; Male; Myocardium; Necrosis; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley | 1995 |
Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats. Role of endothelium and flow.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Carotid Arteries; Endothelium, Vascular; Hypertension; Imidazoles; In Vitro Techniques; Lisinopril; Losartan; Perfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Tetrazoles; Transducers; Vasomotor System | 1995 |
Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Heart Rate; Hypertension, Renal; Imidazoles; Lisinopril; Losartan; Male; Nitroprusside; Rats; Rats, Wistar; Renin-Angiotensin System; Splanchnic Nerves; Sympathetic Nervous System; Tetrazoles | 1995 |
Effects of blocking the angiotensin II receptor, converting enzyme, and renin activity on the renal hemodynamics of normotensive guinea pigs.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Diuresis; Glomerular Filtration Rate; Guinea Pigs; Imidazoles; Kidney Function Tests; Lisinopril; Losartan; Male; Renal Circulation; Renin; Tetrazoles | 1993 |
Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Dihydralazine; Gene Expression Regulation; Heart; Kidney; Lisinopril; Male; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Ribonucleases; RNA, Messenger; Species Specificity | 1995 |
Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
Topics: Angiotensin I; Angiotensin II; Animals; Biphenyl Compounds; Coronary Vessels; Dose-Response Relationship, Drug; Heart; Hypertension, Renovascular; Imidazoles; Lisinopril; Losartan; Male; Necrosis; Rats; Rats, Sprague-Dawley; Tetrazoles | 1995 |
Lisinopril overdose and management with intravenous angiotensin II.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomyopathy, Dilated; Creatinine; Drug Overdose; Humans; Infusions, Intravenous; Lisinopril; Male; Medication Errors; Middle Aged | 1994 |
Angiotensin II receptor binding following myocardial infarction in the rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Biphenyl Compounds; Collagen; Fibrosis; Foreign-Body Reaction; Imidazoles; Lisinopril; Losartan; Male; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles | 1994 |
Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Down-Regulation; Gene Expression Regulation; Imidazoles; Kidney; Lisinopril; Losartan; Male; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Ureteral Obstruction | 1994 |
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Topics: Adipose Tissue, Brown; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Aorta; Bradykinin; Indoles; Kidney; Lisinopril; Lung; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Sprague-Dawley; Renin | 1994 |
Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Endothelins; Female; Gene Expression; Hemodynamics; Hypertension; Imidazoles; Lisinopril; Losartan; Mice; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Reference Values; Tetrazoles | 1994 |
Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockade.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Cyclosporine; Heart; Heart Rate; Kidney; Lisinopril; Liver; Male; Organ Size; Quinolines; Rats; Rats, Wistar; Time Factors; Vasoconstriction; Vasodilation; Vasomotor System; Weight Gain | 1994 |
Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone.
Topics: Aldosterone; Angiotensin II; Animals; Autoradiography; Blood Pressure; Collagen; Coronary Vessels; Fibrosis; Heart; Iodine Radioisotopes; Lisinopril; Male; Myocardium; Nephrectomy; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Sodium, Dietary | 1993 |
Central angiotensin converting enzyme-blockade and thirst.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Drinking; Injections, Subcutaneous; Isoproterenol; Lisinopril; Male; Polyethylene Glycols; Preoptic Area; Rats; Saline Solution, Hypertonic; Thirst; Time Factors | 1993 |
Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Dipeptides; Heart Rate; Imidazoles; Lisinopril; Losartan; Male; Nitric Oxide; Oligopeptides; omega-N-Methylarginine; Pressoreceptors; Rats; Rats, Inbred SHR; Reflex; Tetrazoles | 1993 |
Measurement of angiotensin I converting enzyme inhibition in the heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Captopril; Cricetinae; Dipeptides; Enalaprilat; Humans; Isoquinolines; Lisinopril; Male; Mesocricetus; Papillary Muscles; Tetrahydroisoquinolines | 1993 |
Valvular interstitial cells express angiotensinogen and cathepsin D, and generate angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Aspartic Acid Endopeptidases; Cathepsin D; Cells, Cultured; Dexamethasone; Enzyme Inhibitors; Gene Expression; Haloperidol; Heart Valves; Lisinopril; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger | 1996 |
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chronic Disease; Extracellular Matrix Proteins; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Imidazoles; Kidney; Lisinopril; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Tetrazoles; Transforming Growth Factor beta | 1997 |
Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diastole; Femoral Artery; Heart; Heart Failure; Hemodynamics; In Vitro Techniques; Lisinopril; Male; Muscle, Smooth, Vascular; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Survival Rate; Vascular Resistance; Ventricular Function, Left | 1997 |
Effect of an angiotensin II receptor antagonist, TCV-116, on neointimal formation following balloon injury in the SHR carotid artery.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carotid Arteries; Carotid Artery Injuries; Catheterization; Heart Rate; Lisinopril; Male; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1995 |
Cultured myofibroblasts generate angiotensin peptides de novo.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Aspartic Acid Endopeptidases; beta 2-Microglobulin; Blotting, Western; Cathepsin D; Cells, Cultured; Fluorescent Antibody Technique, Indirect; Gene Expression; Heart Ventricles; Lisinopril; Male; Myocardium; Peptide Biosynthesis; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger | 1997 |
Fibrous tissue and angiotensin II.
Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Connective Tissue; Croton Oil; Fibroblasts; Granuloma; Hydroxyproline; Imidazoles; Lisinopril; Losartan; Macrophages; Male; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Wound Healing | 1997 |
Short-term lisinopril treatment in old rats worsens impairment of angiotensin-induced reflex bradycardia.
Topics: Aging; Angiotensin II; Animals; Antihypertensive Agents; Bradycardia; Lisinopril; Male; Phenylephrine; Rats; Rats, Sprague-Dawley | 1997 |
Actions of angiotensin and lisinopril on thalamic somatosensory neurons in normotensive, non-transgenic and hypertensive, transgenic rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Disease Models, Animal; Electroencephalography; Hypertension; Imidazoles; Lisinopril; Losartan; Male; Neurons, Afferent; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Thalamus; Vasoconstrictor Agents | 1997 |
Different modulation of steroidogenesis and prostaglandin production in frog ovary in vitro by ACE and ANG II.
Topics: Androgens; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dinoprost; Dinoprostone; Estradiol; Female; Gonadal Steroid Hormones; Kidney; Lisinopril; Lung; Ovary; Peptidyl-Dipeptidase A; Progesterone; Prostaglandins; Rabbits; Rana catesbeiana; Rana esculenta | 1997 |
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Heart Rate; Hypertension; Kinetics; Lisinopril; Losartan; Male; Neprilysin; Organophosphonates; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1998 |
Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cell Membrane; Dogs; Humans; Kinetics; Lisinopril; Lung; Models, Chemical; Peptide Fragments; Peptidyl-Dipeptidase A | 1998 |
Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Antihypertensive Agents; Blood Pressure; Heart Rate; Imidazoles; Immunoglobulin G; Lisinopril; Losartan; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Pyridines; Rats; Rats, Inbred SHR; Vasodilation | 1998 |
Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antilymphocyte Serum; Blood Pressure; Cell Division; Creatinine; Glomerulonephritis, Membranoproliferative; Immunoglobulin G; Kidney; Kidney Glomerulus; Lisinopril; Macrophages; Male; Monocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 1998 |
Angiotensin II, VEGF, and diabetic retinopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Glycated Hemoglobin; Humans; Lisinopril; Research Design | 1998 |
Angiotensin II, VEGF, and diabetic retinopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Endothelial Growth Factors; Humans; Lisinopril; Lymphokines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Pouch tissue and angiotensin peptide generation.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Angiotensins; Animals; Aspartic Acid Endopeptidases; Cathepsin D; Collagen; Gene Expression; Imidazoles; Lisinopril; Losartan; Myocardium; Peptide Biosynthesis; Peptides; Peptidyl-Dipeptidase A; Pyridines; Rats; Renin; Transforming Growth Factor beta | 1998 |
Converting enzyme determines plasma clearance of angiotensin-(1-7).
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Chromatography, High Pressure Liquid; Drug Combinations; Half-Life; Lisinopril; Losartan; Male; Metabolic Clearance Rate; Peptide Fragments; Radioimmunoassay; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Species Specificity | 1998 |
The renin-angiotensin system in hybrid NG108-15 cells. Renin gene is from mouse neuroblastoma, angiotensinogen and angiotensin-converting enzyme genes are of rat glioma origin.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Cell Line; DNA Primers; Glioma; Hybrid Cells; Lisinopril; Mice; Neuroblastoma; Peptidyl-Dipeptidase A; Phosphorylation; Polymerase Chain Reaction; Rats; Renin-Angiotensin System; RNA, Messenger | 1998 |
Endogenous angiotensin II and the reflex response to stimulation of cardiopulmonary serotonin 5HT3 receptors.
Topics: Anesthesia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Biguanides; Blood Pressure; Heart Rate; Imidazoles; Infusions, Intravenous; Kidney; Lisinopril; Male; Naphthyridines; Pressoreceptors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Receptor Agonists; Sodium Chloride; Sympathetic Nervous System | 1998 |
Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice.
Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Catecholamines; Humans; Hydralazine; Hypertension; Kidney Diseases; Lisinopril; Mice; Mice, Inbred C57BL; Mice, Transgenic; Renin | 1998 |
Mediation of humoral catecholamine secretion by the renin-angiotensin system in hypotensive rainbow trout (Oncorhynchus mykiss).
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output; Catecholamines; Female; Hypotension; Lisinopril; Male; Oncorhynchus mykiss; Papaverine; Parasympatholytics; Radioimmunoassay; Renin-Angiotensin System; Reproducibility of Results; Vascular Resistance | 1999 |
Renin-angiotensin system stimulates cardiac and renal disorders in Tsukuba hypertensive mice.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Humans; Hydralazine; Hypertension; Kidney Diseases; Lisinopril; Mice; Mice, Inbred C57BL; Renin; Renin-Angiotensin System; Survival Rate | 1999 |
Presence and comparison of angiotensin converting enzyme in commercial cell culture sera.
Topics: Angiotensin II; Animals; Blood Proteins; Bradykinin; Captopril; Cattle; Culture Media; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Horses; Humans; Inhibitory Concentration 50; Kinetics; Lisinopril; Oligopeptides; Peptidyl-Dipeptidase A; Silver Staining | 1999 |
Abated cardiovascular responses to chronic oral lisinopril treatment in conscious elderly rats.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Blood Pressure; Body Weight; Bradycardia; Consciousness; Drinking; Lisinopril; Male; Norepinephrine; Phenylephrine; Rats; Rats, Sprague-Dawley; Sympathomimetics; Vasoconstrictor Agents | 1999 |
Differential response of angiotensin peptides in the urine of hypertensive animals.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Body Weight; Drinking; Electrolytes; Hemodynamics; Hypertension; Lisinopril; Losartan; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley | 1999 |
Angiotensin II induces apoptosis in human and rat alveolar epithelial cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Apoptosis; Cells, Cultured; Epithelial Cells; Humans; Lisinopril; Male; Pulmonary Alveoli; Rats; Rats, Wistar; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Saralasin; Tumor Cells, Cultured | 1999 |
Losartan-induced cough after lisinopril therapy.
Topics: Aged; Angiotensin II; Antihypertensive Agents; Cough; Female; Humans; Lisinopril; Losartan; Randomized Controlled Trials as Topic | 1999 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
Chymase-dependent angiotensin II formation in human vascular tissue.
Topics: Adult; alpha 1-Antitrypsin; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aprotinin; Arteries; Chymases; Female; Heparin; Humans; Lisinopril; Macromolecular Substances; Male; Mast Cells; Middle Aged; Oligopeptides; Protein Binding; Proteoglycans; Serine Endopeptidases; Serine Proteinase Inhibitors | 1999 |
Endothelin, but not angiotensin II, contributes to the hypoxic contractile response of large isolated pulmonary arteries in the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Bosentan; Calcium; Calcium Channel Blockers; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Extracellular Space; Glycopeptides; Hypoxia; In Vitro Techniques; Indoles; Lisinopril; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Pulmonary Artery; Rats; Rats, Wistar; Sulfonamides | 1999 |
Cardiovascular control via angiotensin II and circulating catecholamines in the spiny dogfish, Squalus acanthias.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Physiological Phenomena; Dogfish; Epinephrine; Female; Hypotension; Lisinopril; Male; Norepinephrine; Papaverine; Parasympatholytics; Yohimbine | 1999 |
Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction.
Topics: Adenocarcinoma; Amino Acid Chloromethyl Ketones; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antibodies; Antisense Elements (Genetics); Apoptosis; Cysteine Proteinase Inhibitors; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; fas Receptor; Fibrosis; Gene Expression; Humans; Lisinopril; Lung Neoplasms; Male; Membrane Glycoproteins; Neutralization Tests; Peptidyl-Dipeptidase A; Pulmonary Alveoli; Rats; Rats, Wistar; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Transfection; Tumor Cells, Cultured | 1999 |
Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Imidazoles; Lisinopril; Losartan; NADH Dehydrogenase; NADPH Oxidases; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; Stimulation, Chemical; Superoxides | 1999 |
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Fosinopril; Heart Failure; Humans; Lisinopril; Male; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Treatment Failure; Valine; Valsartan | 2000 |
Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Doxorubicin; Injections, Intraperitoneal; Lisinopril; Male; Nephrosis; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Time Factors | 2000 |
[Refractory shock after converting enzyme inhibitor administration. Usefulness of angiotensin II].
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Female; Fluid Therapy; Humans; Lisinopril; Myocardial Infarction; Norepinephrine; Shock; Vascular Resistance; Vasoconstrictor Agents | 2000 |
Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin II generation de novo.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Apoptosis; Cell Line; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression; Humans; Lisinopril; Lung; Protein Processing, Post-Translational; Receptors, Angiotensin; RNA, Messenger; Saralasin; Tumor Necrosis Factor-alpha | 2000 |
Angiotensin II type 1 receptor blockade abolishes specific K(ATP)channel gene expression in rats with myocardial ischemia.
Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Blotting, Western; DNA, Complementary; Lisinopril; Male; Myocardial Ischemia; Myocardium; Natriuretic Peptide, Brain; Potassium Channels; Potassium Channels, Inwardly Rectifying; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; RNA; RNA, Messenger; Tetrazoles; Time Factors; Up-Regulation | 2000 |
The functional ratio of chymase and angiotensin converting enzyme in angiotensin I-induced vascular contraction in monkeys, dogs and rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Chymases; Dogs; Female; Lisinopril; Macaca; Male; Muscle Contraction; Oligopeptides; Peptidyl-Dipeptidase A; Potassium Chloride; Rats; Rats, Sprague-Dawley; Serine Endopeptidases; Serine Proteinase Inhibitors; Species Specificity; Vasoconstriction | 2000 |
Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Electric Stimulation; Endothelial Growth Factors; Lisinopril; Losartan; Lymphokines; Male; Muscle, Skeletal; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Base Sequence; DNA Primers; Glomerulonephritis; Imidazoles; In Situ Hybridization; Kidney Glomerulus; Lisinopril; Male; Membrane Proteins; Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles | 2001 |
Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Glomerulonephritis; Hyperplasia; Kidney Transplantation; Lisinopril; Male; Oligopeptides; Postoperative Complications; Postoperative Period; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Artery; Renin-Angiotensin System; Tunica Intima | 2001 |
Induction of cardiac fibrosis by angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Collagen; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; Lisinopril; Male; Myocardium; Rats; Rats, Wistar; Telmisartan; Time Factors; Transforming Growth Factor beta | 2000 |
The role of angiotensin II in regulating catecholamine secretion during hypoxia in rainbow trout Oncorhynchus mykiss.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atropine; Epinephrine; Hypoxia; Lisinopril; Methysergide; Muscarinic Antagonists; Nicotine; Norepinephrine; Oncorhynchus mykiss; Oxygen; Receptors, Nicotinic; Renin-Angiotensin System; Serotonin Antagonists; Stress, Physiological | 2001 |
Transforming growth factor-beta(1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts.
Topics: Angiotensin II; Animals; Blotting, Western; Cell Differentiation; Cell Division; Cell Size; Cells, Cultured; Fibroblasts; Lisinopril; Male; Muscle, Smooth; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |
Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Collagen Type III; Disease Progression; Kidney Diseases; Kidney Glomerulus; Lisinopril; Macrophages; Male; Monocytes; Proteinuria; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Valine; Valsartan | 2002 |
ANG II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Dehydration; Gene Expression Regulation; Interleukin-1; Interleukin-6; Lipopolysaccharides; Lisinopril; Liver; Losartan; Male; Rats; Rats, Wistar; RNA, Messenger; Time Factors | 2003 |
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance | 2003 |
Efficacy of losartan in the treatment of erythrocytosis in a young adult with CRF.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Humans; Kidney Failure, Chronic; Lisinopril; Losartan; Male; Polycythemia; Treatment Outcome | 2004 |
Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Brain; Enzyme Induction; Female; Kidney; Lisinopril; Lung; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Organ Specificity; Peptide Fragments; Peptidyl-Dipeptidase A | 2004 |
Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats.
Topics: Actins; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Body Weight; Chronic Disease; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Fibrosis; Genes, ras; Hydroxyproline; Immunohistochemistry; Lisinopril; Male; Organ Size; Pancreatitis; Peptidyl-Dipeptidase A; Peroxidase; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles | 2005 |
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Fibroblasts; Lisinopril; Mice; Mice, Inbred ICR; Mice, Knockout; Neovascularization, Pathologic; NF-kappa B; Peptidyl-Dipeptidase A; Protein Kinase C; Receptor, Angiotensin, Type 1; Sarcoma; Signal Transduction; Tetrazoles; Transcription Factor AP-1; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
The renin-angiotensin system and the developing retinal vasculature.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Animals, Genetically Modified; Autoradiography; Immunoenzyme Techniques; Lisinopril; Losartan; Neovascularization, Physiologic; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Retinal Ganglion Cells; Retinal Vessels | 2005 |
Can angiotensin converting enzyme inhibitors prevent postoperative adhesions?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Lisinopril; Male; Postoperative Complications; Rats; Rats, Wistar; Tissue Adhesions; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Carboxypeptidases; Gene Expression Regulation; Lisinopril; Losartan; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; RNA, Messenger | 2005 |
Angiotensin II mediates glutathione depletion, transforming growth factor-beta1 expression, and epithelial barrier dysfunction in the alcoholic rat lung.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood-Air Barrier; Endotoxemia; Ethanol; Glutathione; Lisinopril; Lung; Lung Diseases; Male; Proteins; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Carboxypeptidases; Gene Expression Regulation, Enzymologic; Hypertension, Renal; Kidney; Lisinopril; Losartan; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Receptors, Angiotensin; Renin-Angiotensin System | 2005 |
Chronic ethanol ingestion increases superoxide production and NADPH oxidase expression in the lung.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Bronchoalveolar Lavage Fluid; Ethanol; Glutathione Disulfide; Lisinopril; Lung; Male; Membrane Glycoproteins; Membrane Transport Proteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; Phosphoproteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Superoxides | 2006 |
Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Congenic; Animals, Genetically Modified; Crosses, Genetic; Hypertension, Renal; Kinetics; Lisinopril; Losartan; Male; Models, Genetic; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; RNA, Messenger; Time Factors | 2006 |
Evidence for tissue angiotensin-converting enzyme in explanted hearts of ischemic cardiomyopathy using targeted radiotracer technique.
Topics: Angiotensin II; Autoradiography; Chymases; Collagen; Humans; Immunohistochemistry; In Vitro Techniques; Lisinopril; Male; Mast Cells; Myocardial Ischemia; Myocardium; Peptidyl-Dipeptidase A; Radiopharmaceuticals; Receptor, Angiotensin, Type 1 | 2007 |
Role of endogenously secreted angiotensin II in the CO2-induced stimulation of HCO3 reabsorption by renal proximal tubules.
Topics: Absorption; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Bicarbonates; Carbon Dioxide; Dose-Response Relationship, Drug; Female; Kidney Tubules, Proximal; Lisinopril; Peptidyl-Dipeptidase A; Rabbits; Renin-Angiotensin System | 2008 |
Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Diet, Sodium-Restricted; Gene Expression Regulation, Enzymologic; Kidney; Lisinopril; Male; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
Antihypertensive mechanism of the dipeptide Val-Tyr in rat aorta.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Dipeptides; Dose-Response Relationship, Drug; Free Radical Scavengers; In Vitro Techniques; Lisinopril; Male; Norepinephrine; Oligopeptides; Potassium Chloride; Rats; Rats, Wistar; Vasoconstriction | 2008 |
Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Brain; Fibrosis; Hemodynamics; Indoles; Infusions, Intravenous; Injections, Subcutaneous; Kidney; Lisinopril; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Renin-Angiotensin System; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2008 |
Angiotensin inhibition stimulates PPARgamma and the release of visfatin.
Topics: Adipocytes; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blotting, Western; Endothelial Cells; Humans; Intra-Abdominal Fat; Lisinopril; Muscle, Skeletal; Nicotinamide Phosphoribosyltransferase; PPAR gamma; Receptor, IGF Type 1; Rosiglitazone; Telmisartan; Tetrazoles; Thiazolidinediones; Umbilical Veins; Valine; Valsartan | 2008 |
Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Kidney; Lisinopril; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A | 2009 |
Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Common Bile Duct; Gene Expression Regulation, Enzymologic; Imidazoles; Leucine; Ligation; Lisinopril; Liver; Liver Cirrhosis, Experimental; Male; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Portal Pressure; Pyridines; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Severity of Illness Index; Thiazepines; Time Factors; Vascular Resistance | 2009 |
Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II- infused ApoE-deficient mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Benzimidazoles; Biphenyl Compounds; Chymases; Disease Progression; Lisinopril; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Tetrazoles | 2009 |
Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Disease Models, Animal; Hypertension; Kidney; Lisinopril; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Vasoconstrictor Agents | 2010 |
Antihypertensive activity of Salvia elegans Vahl. (Lamiaceae): ACE inhibition and angiotensin II antagonism.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Chromatography, Thin Layer; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Injections, Intravenous; Kinetics; Lisinopril; Losartan; Mice; Mice, Inbred ICR; Peptidyl-Dipeptidase A; Plant Components, Aerial; Plant Extracts; Salvia; Spectrophotometry, Ultraviolet | 2010 |
CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.
Topics: Amidines; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blotting, Western; Cells, Cultured; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Hypertension; Lentivirus; Lisinopril; Losartan; Mass Spectrometry; Oligonucleotide Array Sequence Analysis; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2010 |
Angiotensin-converting enzyme is required for normal myelopoiesis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cell Lineage; Lisinopril; Macrophages; Mice; Mice, Knockout; Myelopoiesis; Peptidyl-Dipeptidase A; Substance P; Up-Regulation | 2011 |
Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signaling.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Signaling; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Flow Cytometry; Lisinopril; Mice; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Carboxypeptidase activity common to viridans group streptococci cleaves angiotensin I to angiotensin II: an activity homologous to angiotensin-converting enzyme (ACE).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Base Sequence; Captopril; Carboxypeptidases; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Enalapril; Endocarditis, Bacterial; Fibrinogen; Humans; Lisinopril; Molecular Sequence Data; Peptidyl-Dipeptidase A; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus gordonii | 2011 |
Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiotensins; Animals; Hypertension; Kidney; Lisinopril; Male; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Renin | 2012 |
Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Feedback, Physiological; Genotype; Hypertension; Kidney; Lisinopril; Male; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System | 2012 |
Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Cardiomegaly; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hypertension; Hypertrophy; Kidney; Lisinopril; Mice; Mice, Transgenic | 2014 |
β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats.
Topics: Angiotensin II; Animals; beta Catenin; Blood Pressure; Cyclin D1; Fibrosis; Humans; Hypertension; Kidney; Kidney Diseases; Lisinopril; Proto-Oncogene Proteins c-myc; Pyrvinium Compounds; Rats; Signal Transduction | 2015 |
Local Augmented Angiotensinogen Secreted from Apoptotic Vascular Endothelial Cells Is a Vital Mediator of Vascular Remodelling.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Apoptosis; Cell Line; Human Umbilical Vein Endothelial Cells; Humans; Lisinopril; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Peptidyl-Dipeptidase A; Rats; Vascular Remodeling | 2015 |
The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cytokines; Enzyme Inhibitors; Gastric Mucosa; Imidazoles; Indomethacin; Interleukin-1beta; Lisinopril; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2016 |
Angiotensin Converting Enzyme Regulates Cell Proliferation and Migration.
Topics: Angiotensin II; Animals; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; CHO Cells; Computer Simulation; Cricetulus; Humans; Lisinopril; Melanoma; Peptidyl-Dipeptidase A; Phospholipase C beta; Protein Transport; Vinculin | 2016 |
Screening of inhibitors of angiotensin-converting enzyme (ACE) employing high performance liquid chromatography-electrospray ionization triple quadrupole mass spectrometry (HPLC-ESI-QqQ-MS).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calibration; Chromatography, High Pressure Liquid; Lisinopril; Peptides; Peptidyl-Dipeptidase A; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2017 |
Hyperlipidemia inhibits the protective effect of lisinopril after myocardial infarction via activation of dendritic cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Dendritic Cells; Disease Models, Animal; Heart; Humans; Hyperlipidemias; Lipoproteins, LDL; Lisinopril; Mice; Mice, Knockout; Myeloid Differentiation Factor 88; Myocardial Infarction; Myocardium; NF-kappa B; Signal Transduction; Toll-Like Receptor 4; Ventricular Remodeling | 2020 |
Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Collagen; Fibrosis; Lisinopril; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Diseases; Myocardial Infarction; Smad Proteins; Transforming Growth Factor beta | 2020 |
Time-Dependent Effects of Individual and Combined Treatments With Nebivolol, Lisinopril, and Valsartan on Blood Pressure and Vascular Reactivity to Angiotensin II and Norepinephrine.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Drug Combinations; Hypertension; Lisinopril; Male; Nebivolol; Norepinephrine; Rats, Inbred SHR; Rats, Wistar; Time; Valsartan; Vascular Resistance; Vasoconstrictor Agents | 2021 |
Evaluation of Dual Inhibitory Effect of Anagliptin, Ramipril and Lisinopril on Angiotensin-Converting Enzyme and DPP-4 Activities.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Lisinopril; Pyrimidines; Ramipril; Rats; Rats, Sprague-Dawley | 2022 |
Targeting inflammation and redox perturbations by lisinopril mitigates Freund's adjuvant-induced arthritis in rats: role of JAK-2/STAT-3/RANKL axis, MMPs, and VEGF.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cytokines; Freund's Adjuvant; Inflammation; Interleukin-17; Interleukin-6; Lipid Peroxides; Lisinopril; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; NF-E2-Related Factor 2; NF-kappa B; Oxidation-Reduction; Rats; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2022 |